Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the U.S

Source :: PR Newswire. May 6, 2019
Publication Year :: 2019
Abstract: Six-Year, Multi-Center, Pivotal Clinical Trial Data of LILETTA (levonorgestrel-releasing intrauterine system) 52 mg Presented at 2019 ACOG Meeting SAN FRANCISCO and DUBLIN, May 6, 2019 /PRNewswire/ -- Medicines360, a nonprofit [...]

Subjects :: Allergan PLC -- Product development
Women -- Health aspects
Medical research
Medicine, Experimental
Pregnancy
Levonorgestrel -- Product development
Clinical trials
Pharmaceutical industry -- Product development
Business
News, opinion and commentary
American College of Obstetricians and Gynecologists

Tools